register

Medical and Science

#CytivaThinkPink: Cytiva to donate part of its October sales to breast cancer research

Health Industry Hub | October 7, 2020 |

Every year, Cytiva, a global provider of technologies and services that advance and accelerate the development and manufacture of therapeutics, joins the global fight against breast cancer through its #CytivaThinkPink campaign which is dedicated to supporting the Breast Cancer Research Foundation (BCRF).

For its fourth edition in 2020, the campaign aims to fund 3,300 hours of breast cancer research, 900 more compared to the previous year.

Throughout October 2020, Cytiva will donate $1 to BCRF for every purchase of Mab-Select chromatography resins, Whatman filter papers, Sera-Mag Select reagents and Amersham nitrocellulose membranes. These products are critical in accelerating cancer research and drug development programs.

Emmanuel Abate, Vice President and Head of Genomics and Cellular Research, Cytiva, said “The most common form of cancer in women, breast cancer can have an impact on all of us. People affected by it can be our family members, friends or colleagues. Even while coping with the COVID-19 pandemic, cancer doesn’t slow down and no one can beat this disease alone. We proudly continue to make diagnostic kits, consumables, and instruments used to enable cancer research, and are excited to once again devote time, energy and donations to the important work done by BCRF.”

For Janelle Bryce, Marketing Leader for Australia and New Zealand, the implications of supporting breast cancer research are personal.

“As a breast cancer survivor, I believe that it is crucial to help eliminate the suffering that this debilitating disease brings upon so many of us. research and biotechnology can help save millions of lives when better detection and treatment options are available,” said Ms Bryce.

Breast cancer affects 2.1 million women every year. BCRF is the largest private funder of breast cancer research worldwide, supporting programs on prevention, tumour biology, genetics, treatment, metastasis and survivorship.

In 2020, the #CytivaThinkPink campaign takes place across Australia and New Zealand, United States, Canada, Europe and China. For more information, please visit the Cytiva website.


News & Trends - MedTech & Diagnostics

APAC medtech company scores TGA approval in heart disease

APAC medtech company scores TGA approval in heart disease

Health Industry Hub | October 4, 2024 |

MedTech & Diagnostics News: An Asia Pacific medtech company has announced that its flagship drug-eluting stent (DES) has received regulatory […]

More


News & Trends - MedTech & Diagnostics

New state-based pilot to back home-grown medtech innovation

New state-based pilot to back home-grown medtech innovation

Health Industry Hub | October 4, 2024 |

MedTech & Diagnostics: In a bid to enhance opportunities for local medtech manufacturers to sell to health services, a connected […]

More


News & Trends - Pharmaceuticals

Ferring unveils first real-world evidence for faecal calprotectin approach in ulcerative colitis

Ferring unveils first real-world evidence for faecal calprotectin approach in ulcerative colitis

Health Industry Hub | October 4, 2024 |

Pharma News: Ferring Pharmaceuticals has announced results from a new study, which provides the first real-world evidence supporting the efficacy […]

More


News & Trends - Pharmaceuticals

Bayer partners with RACGP, calls for MBS reforms to boost access to long-acting contraceptives

Bayer partners with RACGP, calls for MBS reforms to boost access to long-acting contraceptives

Health Industry Hub | October 4, 2024 |

Pharma News: Australian women are calling for more accurate information about their contraceptive options, with 70% feeling inadequately educated about […]

More


This content is copyright protected. Please subscribe to gain access.